Asset vs asset
DeXe is a DEXE market beta asset with $340.12M in market cap, while Injective is a INJ market beta asset with $303.19M. The useful comparison is market role, liquidity, seven-day direction, and which follow-up page gives the cleaner next decision.
Comparison Table
| Question | DeXe | Injective |
|---|---|---|
| Market role | DEXE market beta asset | INJ market beta asset |
| Price | $7.27 | $3.03 |
| Market cap | $340.12M | $303.19M |
| 24h volume | $13.39M | $38.31M |
| 7d change | +19.14% | -1.11% |
| Relative size | DeXe is 1.12x Injective's market cap | Injective is 0.89x DeXe's market cap |
| Volume comparison | DeXe trades at 0.35x Injective's 24h volume | Injective trades at 2.86x DeXe's 24h volume |
Use the market-cap calculator when the real question is what one asset would imply at another size.
Open calculatorA cleaner comparison still needs a practical plan for exchanges, withdrawals, and wallets.
Open checklistPut both names back into the wider market context before treating the comparison as a final answer.
Open markets